Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 22, Issue 8, Pages 1103-1114
Publisher
Elsevier BV
Online
2021-06-30
DOI
10.1016/s1470-2045(21)00245-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
- (2020) Weilun Fu et al. Frontiers in Immunology
- Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
- (2020) Benjamin Gesundheit et al. Frontiers in Oncology
- Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection
- (2020) Ashish H. Shah et al. JOURNAL OF NEURO-ONCOLOGY
- Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes
- (2018) Malte Mohme et al. CLINICAL CANCER RESEARCH
- Immunotherapy for brain tumors: understanding early successes and limitations
- (2018) Nicole A. P. Lieberman et al. Expert Review of Neurotherapeutics
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes after second surgery for recurrent glioblastoma: a retrospective case–control study
- (2018) Alysson Wann et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy for brain tumors: understanding early successes and limitations
- (2018) Nicole A. P. Lieberman et al. Expert Review of Neurotherapeutics
- Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
- (2018) E Antonio Chiocca et al. NEURO-ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model
- (2017) Michael E. Barish et al. Stem Cells Translational Medicine
- Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
- (2016) Jana Portnow et al. CLINICAL CANCER RESEARCH
- Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
- (2016) Julius Woongki Kim et al. Journal of Translational Medicine
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction
- (2014) R A Morshed et al. CANCER GENE THERAPY
- A Preclinical Evaluation of Neural Stem Cell–Based Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
- (2013) Atique U. Ahmed et al. JNCI-Journal of the National Cancer Institute
- Neural Stem Cell-Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies
- (2013) K. S. Aboody et al. Science Translational Medicine
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- The Timing of Neural Stem Cell-Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma
- (2013) Alex L. Tobias et al. Stem Cells Translational Medicine
- Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis
- (2012) Yimin Xu et al. MOLECULAR BIOLOGY REPORTS
- Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges
- (2011) M. Kelly Nicholas et al. SEMINARS IN ONCOLOGY
- Neural stem cell systems: physiological players or in vitro entities?
- (2010) Luciano Conti et al. NATURE REVIEWS NEUROSCIENCE
- Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
- (2009) I V Ulasov et al. BRITISH JOURNAL OF CANCER
- Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells
- (2008) Jenilyn J. Virrey et al. AMERICAN JOURNAL OF PATHOLOGY
- Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem Cells
- (2008) S. Nandi et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now